ABVC BioPharma Inc (ABVC)
0.7856
-0.07
(-8.44%)
USD |
NASDAQ |
May 31, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Accounts Receivable (Quarterly): 0.0015M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.0015M |
December 31, 2023 | 0.0015M |
September 30, 2023 | 0.0015M |
June 30, 2023 | 0.0124M |
March 31, 2023 | 0.1241M |
December 31, 2022 | 0.0983M |
September 30, 2022 | 0.0477M |
June 30, 2022 | 0.2895M |
March 31, 2022 | 0.2812M |
December 31, 2021 | 0.2807M |
September 30, 2021 | 0.3314M |
June 30, 2021 | 0.297M |
March 31, 2021 | 0.3925M |
December 31, 2020 | 0.1597M |
September 30, 2020 | 0.1467M |
June 30, 2020 | 0.2018M |
March 31, 2020 | 0.1102M |
December 31, 2019 | 0.1636M |
September 30, 2019 | 0.1314M |
June 30, 2019 | 0.2935M |
March 31, 2019 | 0.1626M |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | |
June 30, 2014 | 0.0012M |
March 31, 2014 | 0.0012M |
December 31, 2013 | 0.0012M |
September 30, 2013 | 0.0012M |
June 30, 2013 | 0.0012M |
March 31, 2013 | 0.0012M |
December 31, 2012 | 0.0012M |
September 30, 2012 | 0.00 |
June 30, 2012 | |
March 31, 2012 | 0.0033M |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0015M
Minimum
Sep 2023
0.3925M
Maximum
Mar 2021
0.1683M
Average
0.1532M
Median
Accounts Receivable (Quarterly) Benchmarks
NeuBase Therapeutics Inc (DELISTED) | 0.00 |
Sutro Biopharma Inc | 31.30M |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | 2.278M |
Journey Medical Corp | 9.799M |